Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study.

Autor: Male C; Department of Paediatrics, Medical University of Vienna., Andersson NG; Centre for Thrombosis and Hemostasis, Skane University Hospital, Malmö, Sweden., Rafowicz A; CRTH, Hopital Bicêtre, Kremlin., Liesner R; Hemophilia Center, Dept. of Hematology, Great Ormond Street Hospital for Children, London., Kurnik K; Dr. V. Haunersches Kinderspital, University of Munich., Fischer K; Van Creveld Kliniek, University Medical Center Utrecht, Utrecht., Platokouki H; Haemophilia-Haemostasis Unit, St. Sophia Children Hospital, Athens., Santagostino E; Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milan., Chambost H; APHM, La Timone Children Hospital, Center for Bleeding Disorders, Marseille., Nolan B; Department of Paediatric Hematology, Children Health Ireland at Crumlin, Dublin., Königs C; J.W. Goethe University Hospital, Department of Pediatrics, Frankfurt., Kenet G; National Hemophilia Center, Ministry of Health, Sheba Medical Center, Tel Hashomer, Israel., Ljung R; Department of Clinical Sciences, Department of Pediatrics, Lund University, Lund, Sweden., Van den Berg M; PedNet Haemophilia Research Foundation, Baarn, The Netherlands.

Publikováno v: Haematologica [Haematologica] 2021 Jan 01; Vol. 106 (1), pp. 123-129. Date of Electronic Publication: 2021 Jan 01.

ADAMTS-13 and bleeding phenotype in von Willebrand disease.

Autor: Boender J; Department of Hematology Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands., Nederlof A; Department of Hematology Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands.; Department of Pediatric Hematology Erasmus MC, University Medical Center Rotterdam Sophia Children's Hospital Rotterdam The Netherlands., Meijer K; Department Hematology University Medical Center Groningen Groningen The Netherlands., Mauser-Bunschoten EP; van Creveld kliniek/Department Benign Hematology University Medical Center Utrecht Utrecht The Netherlands., Cnossen MH; Department of Pediatric Hematology Erasmus MC, University Medical Center Rotterdam Sophia Children's Hospital Rotterdam The Netherlands., Fijnvandraat K; Department of Pediatric Hematology Emma Children's Hospital Amsterdam UMC University of Amsterdam Amsterdam The Netherlands.; Department of Plasma Proteins Sanquin Research Amsterdam Netherlands., van der Bom JG; Department Clinical Epidemiology Leiden University Medical Center Leiden The Netherlands.; Jon J van Rood Center for Clinical Transfusion Medicine Sanquin Research Leiden The Netherlands., de Meris J; Netherlands Hemophilia Society Nijkerk The Netherlands., Laros-van Gorkom BAP; Department Hematology Radboud University Medical Center Nijmegen The Netherlands., van Galen KPM; van Creveld kliniek/Department Benign Hematology University Medical Center Utrecht Utrecht The Netherlands., Eikenboom J; Department Internal Medicine division Thrombosis and Hemostasis Leiden University Medical Center Leiden The Netherlands.; Einthoven Laboratory for Vascular and Regenerative Medicine Leiden University Medical Center Leiden The Netherlands., de Maat MPM; Department of Hematology Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands., Leebeek FWG; Department of Hematology Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands.

Publikováno v: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2020 Oct 31; Vol. 4 (8), pp. 1331-1339. Date of Electronic Publication: 2020 Oct 31 (Print Publication: 2020).

Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A.

Autor: van den Berg HM; PedNet Haemophilia Research Foundation, Baarn, The Netherlands., Fischer K; Van Creveld Kliniek, University Medical Center Utrecht, Utrecht, The Netherlands., Carcao M; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada., Chambost H; Centre de Recherche en Cardiovasculaire et Nutrition (C2VN), Aix Marseille University, Institut National de la Recherche Agronomique (INRA), INSERM, Marseille, France.; Centre for Bleeding Disorders, La Timone Children Hospital, Assistance Publique-Hopitaux de Marseille (APHM), Marseille, France., Kenet G; National Hemophilia Center, Ministry of Health, Sheba Medical Center, Tel Hashomer, Israel., Kurnik K; Dr V. Haunersches Kinderspital, University of Munich, Munich, Germany., Königs C; Clinical and Molecular Hemostasis, Department of Pediatrics and Adolescent Medicine, J .W. Goethe University Hospital, Frankfurt, Germany., Male C; Department of Paediatrics, Medical University Hospital of Vienna, Vienna, Austria., Santagostino E; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy; and., Ljung R; Department of Clinical Sciences and.; Department of Pediatrics, Malmö-Lund University, Lund, Sweden.

Publikováno v: Blood [Blood] 2019 Jul 18; Vol. 134 (3), pp. 317-320. Date of Electronic Publication: 2019 Jun 11.

Primary prophylaxis in haemophilia care: Guideline update 2016.

Autor: Fischer K; Van Creveld Kliniek, University Medical Center Utrecht, Utrecht, The Netherlands., Ljung R; Lund University, Dept. of Clinical Sciences Lund, Paediatrics, Lund, Sweden; Skåne University Hospital, Department of Paediatrics, Malmö Centre for Thrombosis and Haemostasis, Malmö, Sweden. Electronic address: Rolf.Ljung@med.lu.se.

Publikováno v: Blood cells, molecules & diseases [Blood Cells Mol Dis] 2017 Sep; Vol. 67, pp. 81-85. Date of Electronic Publication: 2017 Feb 17.

[Prevention of central nervous system hemorrhages in patients with hemophilia].

Autor: Mauser-Bunschoten EP; Academisch Ziekenhuis Utrecht, Van Creveld Kliniek, Bilthoven., Briët E

Publikováno v: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 1992 Nov 14; Vol. 136 (46), pp. 2257-9.